Evaluation of a Persuasive Health Communication Intervention Designed to Increase HIV/HCV Screening Among Emergency Departments Patients Who Currently, Formerly or Never Injected Drugs.

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

A major impediment to emergency department (ED)-based HIV/HCV screening success is that often ED patients at risk for, or later diagnosed with, HIV and HCV decline testing. In this R01 project, the research team will assess how well a promising, easy-to-use, one-time, minimal-training-needed, very brief persuasive health communication intervention (PHCI) increases acceptance of testing among adult ED patients who either currently, formerly or never injected drugs and initially declined HIV/HCV screening. The research team will conduct a randomized, controlled trial (RCT) at EDs within the Mount Sinai Health System to compare the efficacy of the PHCI when delivered by a video vs. an HIV/HCV counselor. Patients who initially declined HIV/HCV screening will be stratified by injection-drug use (IDU) history cohorts: (1) current/former PWIDs, (2) never/non-PWIDs. Within each IDU history cohort, the research team will randomly assign participants (1:1:1) to a PHCI delivered by: (1) a video with captions, (2) a video without captions, (3) an HIV/HCV counselor. This R01 project will be conducted at Mount Sinai affiliate hospitals EDs. For Aim 2, the research team will determine if screening acceptance is similar across IDU history cohorts. For Aim 3, the research team will further compare the two delivery forms of the PHCI through a health economics assessment, both independent of IDU history and within each IDU history cohort.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• ≥18 years-old

• Speak English or Spanish, and able to provide informed consent for study participation

• Not HIV AND HCV infected/Antibody+ (per EHR review and patient report)

• Not already participating in a HIV or HCV study (e.g., HIV PrEP, HIV vaccine)

• Not tested for HIV OR HCV within the past 12 months (per EHR review and patient report)

Locations
United States
New York
Icahn School of Medicine at Mount Sinai
RECRUITING
New York
Contact Information
Primary
Roland C Merchant, MD
Roland.Merchant@mountsinai.org
(212) 524-9814
Time Frame
Start Date: 2023-12-04
Estimated Completion Date: 2026-08-01
Participants
Target number of participants: 2000
Treatments
Active_comparator: Persuasive Health Communication Intervention delivered in video format with captions
A video with captions created by the research team will be played to persuade patients to participate in HIV and Hepatitis C (HCV) screening.
Active_comparator: Persuasive Health Communication Intervention delivered in video format without captions
A video with captions created by the research team will be played to persuade patients to participate in HIV and Hepatitis C (HCV) screening.
Active_comparator: Persuasive Health Communication Intervention delivered by Health Educator
Healthcare provider educator getting patients screened for HIV/HCV.
Related Therapeutic Areas
Sponsors
Collaborators: National Institute on Drug Abuse (NIDA)
Leads: Icahn School of Medicine at Mount Sinai

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

We couldn't find any related articles check for more on the main search page.